TEMPUS trial finds no added liver-fat benefit from eating windows or exercise

Time-restricted eating, supervised exercise and their combination did not significantly outperform usual care in reducing liver fat in the TEMPUS randomized trial, published October 14 in Nature Communications. The result helps define what these approaches can currently claim for metabolic health.

Researchers in Granada, Spain, randomized 187 adults with obesity, half women, across four groups. The primary endpoint was change in liver fat measured by MRI after 12 weeks. For the combined intervention, the difference versus usual care was −1.1 percentage points, with a 95% confidence interval from −2.7 to 0.5. That interval includes no difference.

Secondary analyses found improvements in fitness and body composition with the combined approach. A male subgroup showed a liver-fat benefit, and an exploratory analysis suggested more participants crossed below the study’s fatty-liver threshold. These findings do not overturn the overall primary result.

What the comparison tested

The trial’s published protocol helps explain the question. Participants assigned to usual care were offered education on Mediterranean dietary patterns and physical activity. The experimental groups added an eight-hour eating window, supervised exercise, or both to that foundation.

The planned education covered practical topics such as interpreting food labels, grocery planning and recognizing satiating foods. Exercise combined resistance work with aerobic interval training under supervision. This makes the comparator important: TEMPUS assessed the additional value of structured programs over an educational intervention.

The protocol also anticipated that restricting eating hours might unintentionally change calorie intake. It specified dietary recalls to assess that possibility, alongside measures of eating habits, physical fitness and body composition. Those separate measurements address different questions. A change in body weight, for example, cannot automatically identify whether timing, food intake or activity produced it.

For readers interpreting the results, the relevant comparison is therefore between assigned programs. The study does not isolate every biological mechanism through which meals and movement might affect the liver.

Why liver fat matters for healthspan

The National Institute of Diabetes and Digestive and Kidney Diseases describes fatty liver disease as excess fat accumulation in the liver, often associated with obesity and type 2 diabetes. More severe disease can involve inflammation and fibrosis, or scarring. Advanced damage can progress to cirrhosis and liver cancer.

Cardiovascular health also matters. NIDDK identifies cardiovascular disease as the most common cause of death among people with fatty liver disease. That broader risk explains why metabolic research should consider more than a single organ measurement.

Earlier research summarized by NIDDK linked more severe fibrosis to higher risks of death and liver complications. That evidence provides context for interpreting an MRI fat endpoint: measuring stored fat is useful, but it does not directly demonstrate prevention of scarring, organ failure or premature death.

How far the finding reaches

A statistically nonsignificant comparison does not establish that two approaches are equivalent. The uncertainty around the estimate leaves room for effects that this experiment could not resolve. Subgroup and exploratory findings are better treated as questions for confirmation than as grounds for selecting a program.

The practical contribution is a more precise evidence boundary. Claims about reducing liver fat, improving fitness and extending healthy life require different supporting outcomes. Future studies need to establish which benefits persist, who experiences them and whether changes in intermediate measurements translate into fewer serious health events.